Trial Profile
A study of palivizumab to investigate rehospitalization rates of premature infants
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2015
Price :
$35
*
At a glance
- Drugs Palivizumab (Primary)
- Indications Respiratory syncytial virus infections
- Focus Therapeutic Use
- 22 Oct 2015 New trial record